TAP Block in Laparoscopic Cholecystectomy.

Assiut University60 enrolled

Overview

Ultrasound-guided transversus abdominis plane block is now widely used in abdominal surgery. Recently, magnesium sulphate is used as adjuvant to local anesthetics.

A significant pain experienced by patients after laparoscopic cholecystectomy surgery is required so as to block nociceptive transmission from both the abdominal wall incision, and visceral sites. Using of opioids can result in significant adverse effects, thus delaying early mobilization of patients. Ultrasound-guided transversus abdominis plane (TAP) block has been used as a satisfactory approach that provides postoperative analgesia. TAP block is safe; it diminishes or replaces the use of opioids; and it has a lower incidence of adverse effects. Bupivacaine is a medication used to decrease feeling in a specific area. It is used by injecting it into the area, around a nerve that supplies the area, or into the spinal canal's epidural space. Bupivacaine is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, and epidural and caudal blocks. Magnesium is the fourth most plentiful cation in our body. It may be worthwhile to further study the role of supplemental magnesium in providing perioperative analgesia, because this is a relatively harmless molecule, is not expensive and also because the biological basis for its potential antinociceptive effect is promising. Magnesium sulphate (MgSO4), N-methyl-D-aspartate receptor antagonist has the potential to be an ideal adjuvant in TAP block.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

QUADRUPLE

Enrollment

Conditions

Postoperative Pain

Interventions

Bupivacaine +magnesium sulphateDRUG

Ultrasound guided subcostal TAP block will performed on both sides using 20 ml volume (0.25 bupivacaine) plus 150 mg of MgSo4

Bupivacaine onlyDRUG

Ultrasound guided subcostal TAP block will performed on both sides using 20 ml volume (0.25 bupivacaine).

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients (age: 18-65 years old) undergoing laparoscopic cholecystectomy. Exclusion Criteria: * Patient refusal * Patients with a history of cardiac, or respiratory diseases ( \>ASA III). * Patients with allergy to amide local anesthetics or medication included in the study. * Infection at the needle insertion site. * Pregnancy * BMI \>35 * Drug abusers

Locations (1)

Faculty of Medicine Assuit University

Asyut, Asyut Governorate, Egypt

Outcomes

Primary Outcomes

The postoperative pain

Visual analogue pain score ranging from 0-10 cm where 0 cm = no pain and 10 cm = the worst imaginable pain.

Time frame: The first 24 hours after surgery

Secondary Outcomes

Time to first dose of post-operative analgesia

hours

Time frame: First occurrence during hospitalization (up to 24 hours postoperatively)

Postoperative nausea and vomiting

A three-point rating scale (1: no postoperative nausea and vomiting, 2: nausea without vomiting, 3: nausea with vomiting).

Time frame: The first 24 hours after surgery

postoperative sedation

Ramsay sedation score as follows: (1) anxious and irritable or dysphoric or both; (2) co-operational, oriented and quiet; (3) responsive to command; (4) asleep, quickly responsive to light tap or loud auditory stimulus; (5) asleep, slowly responsive to light tap or loud auditory stimulus; and (6) asleep, no response to light tap or loud auditory stimulus.

Time frame: The first 24 hours after surgery

Patient satisfaction

Patient satisfaction score ranged from 0-100 points; with 0 indicating the worst level of satisfaction and 100 indicating the best level of satisfaction.

Time frame: At 24 hours after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.